Overview of Available Treatment and New Drug Action Points in Obesity Pharmacology. Will GIP, Glucagon, Amylin Replace GLP-1?. Prospect. Pharm. Sci. 2025, 23 (2), 42-49. https://doi.org/10.56782/pps.361.